Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Neurotoxicities After CAR T-Cell Immunotherapy
Introduction Chimeric antigen receptor (CAR)–modified T-cell immunotherapy can be a highly effective treatment for patients with relapsed and/or refractory hematologic malignancies, but significant adverse effects remain a concern. Systemic cytokine release syndrome (CRS) can occur in association with the inflammatory…